Day: July 11, 2025

HOLLYWOOD, Fla., July 11, 2025 (GLOBE NEWSWIRE) — NV5, a provider of tech-enabled engineering, certification, and consulting solutions, announced today its acquisition of Professional Systems Engineering, LLC, (PSE) a leading designer of facility technologies for corrections and public safety infrastructure throughout the Northeast. Founded in 1986, PSE’s engineers and consultants specialize in the design of security, safety, fire, and communication systems for high-security public sector facilities such as corrections, justice, healthcare, and educational facilities. “NV5 is a leader in the design of audiovisual, fire protection, security, surveillance, and intelligent building systems that employ the latest technologies to improve the safety, function, and comfort of the built environment,” said Ben Heraud, CEO of NV5. “Professional...

WASHINGTON, July 11, 2025 (GLOBE NEWSWIRE) — ASP Isotopes Inc. NASDAQ: ASPI (“ASP Isotopes” or the “Company”), an advanced materials company dedicated to the development of technology and processes for the production of isotopes for use in multiple industries, today announced that at a general meeting of shareholders of Renergen Limited (“Renergen”) held on July 10, 2025, Renergen shareholders voted overwhelmingly in favor of the acquisition of Renergen by ASP Isotopes through a scheme of arrangement (the “Scheme”) in accordance with Sections 114 and 115 of the South African Companies Act, No. 71 of 2008. The Scheme received support from 99.80% of voting shareholders. The implementation of the Scheme remains subject to and will only become operative upon the fulfilment or, if applicable, waiver of a number of conditions,...

BOSTON, July 11, 2025 (GLOBE NEWSWIRE) — Ikena Oncology, Inc. (Nasdaq: IKNA, “Ikena,” the “Company”) today announced that Institutional Shareholder Services Inc. (“ISS”) and Glass, Lewis & Co. (“Glass Lewis”) recommend that stockholders vote FOR the issuance of shares in connection with the previously disclosed proposed merger with Inmagene Biopharmaceuticals (“Inmagene”) at Ikena’s upcoming Annual Meeting of Stockholders on July 15, 2025. ISS and Glass Lewis are leading U.S. institutional voting advisory services that regularly publish analyses on public shareholder votes. Inmagene is a privately held, clinical stage biopharmaceutical company focused on developing IMG-007, a nondepleting anti-OX40 monoclonal antibody (mAb) engineered to have a silenced antibody-dependent cellular cytotoxicity (ADCC) function to minimize potential...

Extraordinary General Meeting of Helix Shareholders Scheduled for August 4, 2025 SOUTH SAN FRANCISCO & BOSTON, July 11, 2025 (GLOBE NEWSWIRE) — Helix Acquisition Corp. II (“Helix”) (Nasdaq: HLXB), a special purpose acquisition company (“SPAC”) sponsored by Cormorant Asset Management, and TheRas, Inc. (d/b/a BridgeBio Oncology Therapeutics) (“BBOT”), a clinical-stage biopharmaceutical company advancing a next-generation pipeline of novel small molecule therapeutics targeting RAS and PI3Kα malignancies, today announced that the registration statement on Form S-4 (File No. 333-288222) (as amended, the “Registration Statement”), filed by Helix and BBOT, relating to the previously-announced business combination among Helix, BBOT, and the other parties thereto (the “Business Combination”), has been declared effective by the U.S....